OneMedNet shares surge 70.10% intraday due to industry reports on AI innovation and regulatory growth in medical AI.
ByAinvest
Friday, Feb 27, 2026 10:21 am ET1min read
ONMD--
OneMedNet surged 70.10% intraday, driven by its AI-ready real-world data platform for digital medical imaging and AI model development, a February 2026 broker report highlighting AI-driven medical innovation, and a February 2026 National Medical Products Administration report showing a 17% year-on-year increase in AI-related medical device approvals in 2025, boosting industry growth.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet